Teva tops expectations on surging sales
Published by Live Search News: "Food and Drug Administration" November 7th, 2006 in Regulatory AffairsCNN Money - Food and Drug Administration. The brand products covered by these applications have annual U.S. sales of $87 billion. Global sales of Copaxone, Teva’s multiple sclerosis drug, rose 15 percent in the quarter to $354 million. The board declared a cash …